Today: 21 May 2026
Tesla stock rises as Musk puts a Feb. 14 deadline on buying Full Self-Driving outright
15 January 2026
2 mins read

Tesla stock rises as Musk puts a Feb. 14 deadline on buying Full Self-Driving outright

New York, Jan 15, 2026, 10:16 EST — Regular session

  • Tesla shares edged up roughly 0.6% in early trading, following strength in major tech stocks.
  • CEO Elon Musk announced Tesla will end one-time purchases of its Full Self-Driving software after Feb. 14, shifting exclusively to a subscription model.
  • Tesla has also agreed to mediation with the U.S. EEOC over a racism lawsuit linked to its Fremont, California factory.

Tesla shares climbed Thursday following CEO Elon Musk’s announcement that the company plans to eliminate the one-time purchase option for its Full Self-Driving (FSD) software next month, switching buyers exclusively to a subscription model.

This shift is key as investors now see Tesla more as a software and services company than just an automaker, especially with its quarterly results due later this month. Subscription income tends to be more stable than one-time sales, but it also raises sharper scrutiny on Tesla’s safety and self-driving promises.

Musk announced on X that “Tesla will stop selling FSD after Feb 14,” noting it “will only be available as a monthly subscription thereafter.” Electrek

In the U.S., Tesla offers FSD (Supervised) for a one-time fee of $8,000 or a subscription at $99 per month, according to Reuters. The system assists drivers but doesn’t make the vehicle fully autonomous, demanding that drivers remain alert and ready to take control.

U.S. auto safety officials have zeroed in on Tesla’s driver-assistance tech. Last year, the National Highway Traffic Safety Administration launched an investigation into 2.88 million Teslas fitted with Full Self-Driving (FSD), following reports of crashes and traffic violations, Reuters reported.

Skeptics pounced on the pricing change as an implicit reset. GLJ Research analyst Gordon Johnson called the whole narrative “retired,” saying the shift to subscription-only damages the notion of FSD as an “appreciating asset.” TipRanks

Tesla isn’t the only automaker pushing software subscriptions anymore. Rivian will offer its Autonomy+ system for a one-time $2,500 charge or $49.99 monthly, according to MotorTrend. Meanwhile, established carmakers have broadened their paid driver-assistance options.

In a parallel development, Tesla has agreed to mediation with the U.S. Equal Employment Opportunity Commission over allegations of racial harassment at its Fremont facility. The EEOC indicated talks might kick off in March or April. Should those negotiations break down, both parties must submit their plans for next steps to the judge by June 17.

Tesla’s upcoming earnings report is the next big event to watch. The company will release its fourth-quarter 2025 results after the market closes on Jan. 28, with a management Q&A webcast scheduled for 5:30 p.m. Eastern.

Investors are keen for details on demand, pricing, and margins, with a close eye on how fast subscription sign-ups might offset traditional upfront software sales. Attention will also focus on Tesla’s approach to regulatory pressure concerning its driver-assistance systems.

Tesla reported delivering 418,227 vehicles in the fourth quarter while producing 434,358. The company also hit a record with energy-storage deployments reaching 14.2 GWh.

The shift to subscriptions isn’t without risk. It might accelerate $8,000 purchases into next month, creating a dip afterward. Plus, ongoing regulatory scrutiny or new setbacks could dampen customer interest.

On the broader tape, the Invesco QQQ climbed roughly 0.9%, with the SPDR S&P 500 ETF adding around 0.5%. Meanwhile, electric vehicle rivals Rivian and Lucid slipped lower.

Traders have marked two key dates for Tesla: Jan. 28, when the company will release its results and guidance, and Feb. 14, the deadline to purchase FSD outright in the U.S.

Stock Market Today

  • Clarity Pharmaceuticals Shares Surge 9.33% on ASX Amid Biotech Sector Rally
    May 21, 2026, 10:09 AM EDT. Clarity Pharmaceuticals Ltd (ASX: CU6) shares jumped 9.33% to A$2.76 on May 21, 2026, driven by renewed investor interest in Australian biotech stocks. The stock's rise occurred despite below-average trading volume of 1.41 million shares, indicating limited market conviction. Clarity's market capitalization stands near A$994 million, but the company remains unprofitable with a trailing twelve months (TTM) diluted earnings per share (EPS) of -0.28 AUD and a year-over-year EPS decline of 70.72%. Investors appear hopeful for potential near-term catalysts such as partnering or licensing deals that commonly stimulate mid-cap biotech stocks. The price advance reflects sector sentiment more than fundamental improvement, underscored by the absence of a meaningful price-to-earnings (P/E) ratio due to ongoing losses.

Latest articles

Stellantis Launches $70 Billion Overhaul With Focus on Jeep, Ram, China

Stellantis Launches $70 Billion Overhaul With Focus on Jeep, Ram, China

21 May 2026
Stellantis announced a €60 billion, five-year plan Thursday, focusing investment on Jeep, Ram, Peugeot, Fiat, and its commercial vehicles. Shares dropped over 5% in early European trading after the announcement. The company aims to launch over 60 new vehicles by 2030 and cut development cycles to 24 months. CEO Antonio Filosa is targeting 25% North American revenue growth and €6 billion in annual cost reductions.
Nike stock climbs but analysts hold back on turnaround calls

Nike stock climbs but analysts hold back on turnaround calls

21 May 2026
Nike shares climbed 3.4% to $44.07 Wednesday as falling oil prices and lower U.S. Treasury yields boosted consumer stocks. Nike reported flat quarterly revenue at $11.3 billion, with direct-to-consumer sales down 4% and net income down 35%. The company plans to launch a Google Gemini-powered shopping feature in June. Nike’s global footwear market share slipped to 22.9% in 2025, while Adidas gained, Reuters said.
Infleqtion shares react to $100 million quantum funding news in Washington

Infleqtion shares react to $100 million quantum funding news in Washington

21 May 2026
Infleqtion shares rose 5.1% premarket Thursday after the U.S. Commerce Department signed a preliminary $100 million funding letter for its neutral-atom quantum computing project, which would also give the government stock in the company. The proposed award, not yet final, is contingent on milestones and approvals. INFQ last traded at $11.18 before the New York open. D-Wave and Rigetti also saw premarket gains.
POET Technologies stock climbs before the bell as call-option volume spikes
Previous Story

POET Technologies stock climbs before the bell as call-option volume spikes

Opendoor Technologies stock slips today as mortgage applications surge and Treasuries stay stubborn
Next Story

Opendoor Technologies stock slips today as mortgage applications surge and Treasuries stay stubborn

Go toTop